GSAC
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation is headquartered in Palm City, Florida.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | 0.00 | $80,081 | -$15,494 |
| 2025 Q1 | 0.00 | $64,519 | -$15,494 |
| 2024 Q4 | 0.00 | $117,247 | -$4,357 |
| 2024 Q3 | 0.00 | $117,247 | -$4,357 |
| 2024 Q2 | 0.00 | $77,923 | -$24,227 |
| 2024 Q1 | -0.00 | $57,618 | -$24,227 |
| 2023 Q4 | 0.00 | $62,437 | -$49,409 |
| 2023 Q3 | -0.00 | $34,705 | -$79,856 |